Drug Search Results
More Filters [+]

Turofexorate isopropyl

Alternative Names: turofexorate isopropyl, fxr-450, fxr450, fxr 450
Latest Update: 2010-10-22
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: FXR Agonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Pfizer
Company Location: NEW YORK NY 10017
Company CEO: Albert Bourla
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Turofexorate isopropyl

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 1: Healthy Volunteers

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

3213A1-1002

P1

Terminated

Healthy Volunteers

2008-02-01

3213A1-1000

P1

Completed

Healthy Volunteers

2008-02-01

Recent News Events

Date

Type

Title